Article Details
Retrieved on: 2025-10-10 18:43:46
Tags for this article:
Click the tags to see associated articles and topics
Excerpt
The company believes its lead drug, which is currently in mid-stage testing, could address limitations of other therapies for chronic skin hives.
Article found on: www.biopharmadive.com
This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.
Sign UpAlready have an account? Log in here